Site Map

Home

About Us

• Overview
• Historical Timeline
• Executive Team
• Board of Directors
• Corporate Responsibility
  • Corporate Giving and Grants
    • Grant Guidelines
    • Submit a Grant Request
  • Prescriber Data Privacy
  • Code of Conduct
  • Compliance Reporting
  • Corporate Compliance
  • Policy on Data Privacy
  • Patents
• Corporate Values
• Partnering with Onyx
  • Partnerships
• Awards and Recognitions
• Contact Us

Therapies

• Overview
• Nexavar ® (sorafenib) Tablets
  • Nexavar ® (sorafenib) Tablets for Advanced Kidney Cancer
    • About Kidney Cancer
    • Resources
  • Nexavar ® (sorafenib) Tablets for Unresectable Liver Cancer
    • About Liver Cancer
    • Resources
  • Patient Access
    • REACH® for Nexavar
• Kyprolis ® (carfilzomib) for Injection
  • Patient Access
    • Onyx Pharmaceuticals 360™ (Onyx 360)
• Patient Access
  • REACH® for Nexavar
  • Onyx Pharmaceuticals 360™ (Onyx 360)

Clinical Development

• Overview
• Clinical Pipeline
• Sorafenib
  • Kidney Cancer
  • Liver Cancer
  • Thyroid Cancer
  • Breast Cancer
• Carfilzomib
  • Multiple Myeloma
• Oprozomib
  • Solid Tumors
• ONX 0914
• Palbociclib
• Investigator Sponsored Trials

Investors

• Investors
• Event Calendar
• Analyst Coverage
• SEC Filings
• Financial Information
• Stock Information
• Annual Report
• Proxy Materials
• Corporate Governance
  • Board of Directors
  • Board Committees
  • Code of Conduct
  • Trading Policy
• Information Request

News & Media

• Overview
• Press Releases
  • Current Press Releases
  • 2012 Press Releases
  • Press Releases 2011
  • Press Releases 2010
  • Press Releases 2009
• Online Media Kit

Careers

• Careers
• Job Openings
• Benefits
• How to Apply